Profil
Mike Wood is currently working as a Research Director at Ligand UK Ltd.
since 2004 and as a Managing Director at Vernalis (R&D) Ltd.
since 2019.
He previously worked as the Head-Preclinical Development at RiboTargets Ltd.
Postes actifs de Mike Wood
| Sociétés | Poste | Début |
|---|---|---|
| VERNALIS | Chief Tech/Sci/R&D Officer | 01/02/2004 |
Vernalis (R&D) Ltd.
 Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Vernalis (R&D) Ltd. engages in the research development of biotechnology and pharmaceutical products manufacturing. The company was founded on February 4, 1986 and is headquartered in Wokingham, the United Kingdom. | Chief Executive Officer | 01/01/2019 |
Anciens postes connus de Mike Wood
| Sociétés | Poste | Fin |
|---|---|---|
| RiboTargets Ltd. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1986 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| RiboTargets Ltd. | Health Technology |
Vernalis (R&D) Ltd.
Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Vernalis (R&D) Ltd. engages in the research development of biotechnology and pharmaceutical products manufacturing. The company was founded on February 4, 1986 and is headquartered in Wokingham, the United Kingdom. | Health Technology |
